Sort
16,300 grants matching “fatty liver disease”
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$526,078Edgar G. Engleman · Stanford University · R01 · FY2021 · CA
Metabolic Syndrome--Prepubertal African Amer./Caucasian
$526,000Melinda S Sothern · Lsu Health Sciences Center · R01 · FY2007 · HD
Tissue Mechanisms of Aging in the Genetic Model C. elegans
$525,716James R Priess · Fred Hutchinson Cancer Center · R01 · FY2024 · AG
Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction
$525,673Erin Seifert · Thomas Jefferson University · R01 · FY2025 · DK
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population
$525,583Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2023 · DK
Lipotoxicity and Liver Inflammation
$525,565Samar Ibrahim · Mayo Clinic Rochester · R01 · FY2025 · DK
Inflammation and hepatic lipid metabolism
$525,426Alan R. Saltiel · University Of California, San Diego · R01 · FY2023 · DK
Inflammation and hepatic lipid metabolism
$525,426Alan R. Saltiel · University Of California, San Diego · R01 · FY2022 · DK
Inflammation and hepatic lipid metabolism
$525,426Alan R. Saltiel · University Of California, San Diego · R01 · FY2021 · DK
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$525,319Carol A Casey · University Of Nebraska Medical Center · R01 · FY2022 · AA
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$525,319Carol A Casey · University Of Nebraska Medical Center · R01 · FY2025 · AA
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$525,319Carol A Casey · University Of Nebraska Medical Center · R01 · FY2023 · AA
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$525,319Carol A Casey · University Of Nebraska Medical Center · R01 · FY2024 · AA
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
$525,092Timothy F Osborne · Johns Hopkins University · R01 · FY2023 · DK
PPAR Mediated Gene Expression in HIV Patients
$524,962State University New York Stony Brook · R01 · FY2004 · DK
Role of DGAT in triacylglycerol meatabolism
$524,880Robert V Farese · J. David Gladstone Institutes · R01 · FY2009 · DK
Alpha and Beta Cell Function in Normal and Diabetic Man
$524,511University Of Rochester · R01 · FY2004 · DK
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
$524,457Michael Karin · University Of California, San Diego · R01 · FY2024 · DK
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis
$524,393Howard J Worman · Columbia University Health Sciences · R01 · FY2020 · DK
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis
$524,393Howard J Worman · Columbia University Health Sciences · R01 · FY2021 · DK
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis
$524,391Howard J Worman · Columbia University Health Sciences · R01 · FY2022 · DK
USC Cirrhosis Clinical Center
$524,271Norah A. Terrault · University Of Southern California · U01 · FY2023 · DK
Coactivator P300 promotes hepatic steatosis in obesity
$523,897Ling He · Johns Hopkins University · R01 · FY2023 · DK
Developmental flame retardant exposure, gut microbiome, and obesity
$523,875Julia Yue Cui · Oregon State University · R01 · FY2025 · ES
Novel pathophysiological insights into mitochondrial fatty acid oxidation disorders
$523,838Sander Michel Houten · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DK